$185 Million is the total value of New Leaf Venture Partners, L.L.C.'s 14 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 80.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
MRNS | Sell | MARINUS PHARMACEUTICALS INC | $1,309,000 | -62.3% | 342,550 | -19.4% | 0.71% | -56.4% |
OTIC | Exit | OTONOMY INC | $0 | – | -109,825 | -100.0% | -0.28% | – |
ALDR | Exit | ALDER BIOPHARMACEUTICALS INC | $0 | – | -171,364 | -100.0% | -0.92% | – |
SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -25,000 | -100.0% | -1.93% | – |
IRTC | Exit | IRHYTHM TECHNOLOGIES INC | $0 | – | -328,741 | -100.0% | -8.62% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
DECIPHERA THERAPEUTICS INC | 25 | Q3 2023 | 44.4% |
CHIMERIX INC | 25 | Q1 2023 | 20.9% |
SIERRA ONCOLOGY INC | 22 | Q2 2022 | 14.9% |
ARVINAS INC | 21 | Q3 2023 | 44.8% |
CRINETICS PHARMACEUTICALS INC | 21 | Q3 2023 | 11.4% |
OBSEVA SA | 20 | Q4 2021 | 8.5% |
AVROBIO INC | 20 | Q1 2023 | 1.7% |
HARPOON THERAPEUTICS INC | 19 | Q3 2023 | 20.0% |
ALECTOR INC | 19 | Q3 2023 | 4.6% |
ITERUM THERAPEUTICS PLC | 18 | Q3 2022 | 3.8% |
View New Leaf Venture Partners, L.L.C.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-14 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-10 |
13F-HR | 2023-05-11 |
13F-HR | 2023-02-06 |
13F-HR | 2022-11-10 |
13F-HR | 2022-08-09 |
13F-HR | 2022-05-06 |
13F-HR | 2022-02-11 |
View New Leaf Venture Partners, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.